FDA approves Zeiss software that treats nearsightedness
January 12, 2024
Zeiss Medical Technology announced that the FDA approved the VisuMax 800 with Smile Pro software.
Zeiss Medical Technology announced that the FDA approved the VisuMax 800 with Smile Pro software.
Neuralace Medical announced today that it received FDA clearance for its chronic painful diabetic neuropathy (PDN) treatment.
Zeta Surgical announced today that the FDA granted it a special 510(k) clearance for expanded software functionality.
3Spine’s MOTUS device is a ‘first-of-kind’ breakthrough medical technology indicated for the biomechanical reconstruction and stabilization of a spinal motion segment
The innovative medical robotic startup achieved the globally recognized ISO 13485 certification in December 2023
Neurolief announces the approval of its neuromodulation device, Relivion®, by the Japanese Ministry of Health, Labor and Welfare (MHLW).
Johnson & Johnson MedTech’s Biosense Webster today announced Japanese approval for its Varipulse platform for treating AFib.
An international research team has shown that the debilitating impact of tinnitus can be effectively reduced in just weeks by a training course and sound therapy delivered via a smartphone app
SCHAFFHAUSEN, CH / ACCESSWIRE / January 8, 2024 / Occlutech Holding AG Occlutech ASD Occluder delivers positive procedural outcomes with strong efficacy and a low rate of complications[i]
SimBioSys announced that it received FDA 510(k) clearance for its TumorSight cloud-based digital precision medicine platform.